-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Moderator Introduction (Malignant Hematology Perspective)

Scientific Workshop on Genomic Toxicities of Gene and Cell Therapies
Program: Scientific Workshops
Session: Understanding Immediate Toxicities of Current Gene and Cell Therapy Tools
Friday, December 6, 2024, 2:03 PM-3:00 PM

Saar Gill, MD, PhD

University of Pennsylvania, Philadelphia, PA

Disclosures: Gill: Mission Bio: Membership on an entity's Board of Directors or advisory committees; Asher Biotherapeutics: Research Funding; Novartis: Patents & Royalties, Research Funding; Carisma: Current holder of stock options in a privately-held company; Interius: Current holder of stock options in a privately-held company, Research Funding.